90 likes | 111 Vues
Get more details @ http://bit.ly/2nUpHlT <br>Some of the key companies providing products and services in the digital genome market are Thermo Fisher, Perkin Elmer, Qiagen, Illumina, Becton Dickinson. Agilent, Sigma Aldrich, Fluidigm, Pacific Biosciences, F. Hoffmann-La Roche, Agios, AVEO Oncology and Biomarin, BioReference.
E N D
Research and Development led the Digital Genome Market share to exceed $23bn by 2024: Global Market Insights Inc. Fuel Cell Market size worth $25.5bn by 2024
KeyInsights from Digital Genome Market: • On-going research activities along with supportive regulations across the globe will revolutionize digital genome market. • The growing implementation of this technology in the field of personalized medical care for efficient disease management will noticeably favor digital genome industry share. • The prominent applications of digital genome industry are microbiology, reproductive & genetic, research & development, transportation, and livestock & agriculture sectors. • Microbiology application segment accounted for more than 22% of the revenue share in 2015 and will surpass a revenue collection of USD 10 billion by 2024. • Research & development dominated the application landscape in 2015 and will contribute a revenue of more than USD 23 billion by 2024. • Sequencing and analysis software, one of the product bifurcations of digital genome market, will register an annual growth rate of 9.8% over the period of 2016 to 2024, owing to the increasing efforts to upgrade software packages.
Continued... • China digital genome market size will grow at an annual growth rate of more than 10% over the period of 2016 to 2024. • U.S. digital genome market covered over 80% of the North America regional share in 2015 and will generate significant revenue over the coming seven years, owing to the genome sequencing technological enhancements along with availability of advanced healthcare infrastructure. • Brazil digital genome market is anticipated to record a considerable growth rate over the coming timeframe. The supportive rules and regulations regarding genetic and clinical testing will augment the business growth. • Russia digital genome market collected a revenue of around USD 290 million in 2015 and will exhibit lucrative growth over the coming years of 2016 to 2024, primarily driven by the fierce competition prevalent in the region. • The corporations operating in digital genome market are Becton Dickinson, Agilent Technologies, Qiagen, Thermo Fisher Scientific, Illumina, Pacific Biosciences, Perkin Elmer, Sigma-Aldrich, BioMarin Pharmaceutical, Fluidigm Corporation, Bio-Reference Laboratories, AVEO Oncology, and Agios.
Germany Digital Genome Market size, by product, 2012-2024 (USD Million)
Browse Full Market Research Report On Digital Genome Market @ http://bit.ly/2oqb3Xv Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/1219https://www.gminsights.com/request-sample/detail/49
Table of Content: Chapter 1. Methodology and Scope 1.1. Methodology 1.1.1. Initial data exploration 1.1.2. Statistical model & forecast 1.1.3. Industry insights & validation 1.1.4. Scope, definitions & research assumptions 1.2. Data Sources 1.2.1. Primary 1.2.2. Secondary Chapter 2. Executive Summary 2.1. Digital Genome industry 3600 synopsis, 2012 – 2024 (USD Million) 2.1.1. Business trends 2.1.2. Product trends 2.1.3. Application trends 2.1.4. End-use trends 2.1.5. Regional trends
Table of Content: Chapter 3. Digital Genome Industry Insights 3.1. Industry segmentation 3.2. Industry size and forecast, 2012 – 2024 (USD Million) 3.3. Industry impact forces 3.3.1. Growth drivers 3.3.1.1. Successful completion of the Human Genome Project 3.3.1.2. Increasing public-private investments, funds, and grants 3.3.1.3. Advances in biotechnology 3.3.1.4. Increased Application in clinical diagnosis 3.3.1.5. Rising use of personalized medicine 3.3.1.6. Rise in incidence and prevalence of chronic diseases 3.3.1.7. Reduced cost and high speed for DNA sequencing
Table of Content: 3.3.2. Industry pitfalls & challenges 3.3.2.1. Unclear ROI of precision medicine 3.3.2.2. Lack of trained staff 3.4. Growth potential analysis 3.5. Porter's analysis 3.6. Technology landscape 3.6.1. Advent of novel technologies 3.7. Company market share analysis, 2015 3.7.1. Strategy dashboard 3.8. PESTEL analysis
Stay In Touch Website: www.gminsights.com Social Media: